Literature DB >> 2688217

Polymorphism of cytochrome P-450 in humans.

F P Guengerich.   

Abstract

A number of different cytochrome P-450 proteins are found in human liver and other tissues. These enzymes oxidize drugs and carcinogens as well as endogenous chemicals such as steroids and eicosanoids. As Peter Guengerich explains, activities of individual cytochrome P-450 enzymes vary among individuals as a result of both genetic and environmental influences; in some cases, the mechanisms are known. Such variation can have major influences in determining drug toxicity, inborn errors of steroid metabolism, and possibly cancer risk.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688217     DOI: 10.1016/0165-6147(89)90207-1

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  10 in total

Review 1.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.

Authors:  Hermann M Bolt; Peter H Roos; Ricarda Thier
Journal:  Int Arch Occup Environ Health       Date:  2003-03-01       Impact factor: 3.015

2.  Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells.

Authors:  Lawrence H Lash; David A Putt; Hongliang Cai
Journal:  Toxicology       Date:  2007-11-04       Impact factor: 4.221

Review 3.  Biochemical applications of ultrathin films of enzymes, polyions and DNA.

Authors:  James F Rusling; Eli G Hvastkovs; Dominic O Hull; John B Schenkman
Journal:  Chem Commun (Camb)       Date:  2007-08-30       Impact factor: 6.222

4.  Lack of defect in oxidative hydroxylation of debrisoquine in a patient with halothane hepatitis.

Authors:  M Toutoungi; D Magnenat
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA.

Authors:  Sandra M Swain; Young-Hyuck Im; Seock-Ah Im; Valorie Chan; David Miles; Adam Knott; Emma Clark; Graham Ross; José Baselga
Journal:  Oncologist       Date:  2014-05-28

Review 6.  Drug interactions with cisapride: clinical implications.

Authors:  E L Michalets; C R Williams
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

7.  Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17 beta-estradiol.

Authors:  W Schubert; U Eriksson; B Edgar; G Cullberg; T Hedner
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jul-Sep       Impact factor: 2.441

8.  Gene expression of cytochromes P450 in liver transplants over time.

Authors:  Mari Thörn; Stefan Lundgren; Gustaf Herlenius; Bo-Göran Ericzon; Lars Lööf; Anders Rane
Journal:  Eur J Clin Pharmacol       Date:  2004-06-10       Impact factor: 2.953

Review 9.  Omeprazole drug interaction studies.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

10.  Characterisation of the metabolites of 1,8-cineole transferred into human milk: concentrations and ratio of enantiomers.

Authors:  Frauke Kirsch; Andrea Buettner
Journal:  Metabolites       Date:  2013-01-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.